London’s GHO, Singapore’s CBC to merge into $21 billion healthcare investor

Industry:    5 days ago

London-based Global Healthcare Opportunities (GHO) and Singapore’s CBC Group ‌on Wednesday said they would merge, creating what they called the world’s largest healthcare-focused investment manager with more than $21 billion in assets.

The deal brings together two specialist healthcare investors as financial firms ​globally seek greater scale and a wider reach in private markets.

It also comes as ​ageing populations, rising medical costs and faster use of technology are ⁠drawing more capital into drug development, medical devices, diagnostics, healthcare infrastructure and health technology.

The ​combined company will have more than 200 investment and operating professionals in 13 offices ​across North America, Europe and Asia-Pacific, the firms said in a statement.

Those regions account for about 90% of global healthcare research and development spending, they added.

The Financial Times first reported about the planned ​merger on Wednesday.

The transaction is expected to close in early 2027, subject to ​regulatory approvals and other customary conditions, according to their statement. GHO and CBC will operate separately until ‌the ⁠deal is completed.

CBC founder and CEO Fu Wei and GHO co-founder and managing partner Mike Mortimer will become co-chief executives of the combined firm, the statement said. GHO co-founder and Vice Chair Lady Mireille Gillings and Fu will co-chair the board.

GHO said ​the deal would give ​its North American ⁠and European portfolio companies stronger access to Asia-Pacific, while CBC said its Asian healthcare companies would gain from wider global market insight ​and support.

“In particular, AI is a fast-evolving force in healthcare ​and life ⁠sciences and so AI applications in these fields will continue to be a focus moving forward,” said Gillings.

GHO has $10.5 billion in assets under management, while CBC has $10.8 billion, according to ⁠the ​statement.

Existing funds and portfolio companies will remain under their ​current investment teams, with no changes to mandates, governance or ownership, they added.

print
Source: